Literature DB >> 28771668

Safety and efficacy of topical timolol treatment of infantile haemangioma: a prospective trial.

J Borok1,2, P Gangar1,3, S Admani1,4, J Proudfoot5, S F Friedlander1,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28771668     DOI： 10.1111/bjd.15865

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  8 in total

1.  Absorption and Safety of Topically Applied Timolol for Treatment of Chronic Cutaneous Wounds.

Authors:  Anthony Cole Gallegos; Michael James Davis; Catherine N Tchanque-Fossuo; Kaitlyn West; Angela Eisentrout-Melton; Thomas R Peavy; Roy W Dixon; Roma P Patel; Sara Evona Dahle; Roslyn Rivkah Isseroff
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-10-16       Impact factor: 4.730

Review 2.  Medical Management of Infantile Hemangiomas: An Update.

Authors:  Caroline Colmant; Julie Powell
Journal:  Paediatr Drugs       Date:  2021-10-22       Impact factor: 3.022

3.  Good Clinical Responders to Topical Timolol in Patients with Infantile Hemangiomas: A 7-Year Retrospective Study of 328 Korean Patients.

Authors:  Da-Ae Yu; Se Hee Min; Jaeryong Song; Jong Seo Park; Hanjae Lee; Jungyoon Ohn; Kyu Han Kim
Journal:  Ann Dermatol       Date:  2022-10       Impact factor: 0.722

Review 4.  Repurposing Ophthalmologic Timolol for Dermatologic Use: Caveats and Historical Review of Adverse Events.

Authors:  Daniel J Yoon; Ramanjot Kaur; Anthony Gallegos; Kaitlyn West; Hsinya Yang; Saul Schaefer; Catherine Tchanque-Fossuo; Sara E Dahle; R Rivkah Isseroff
Journal:  Am J Clin Dermatol       Date:  2020-11-25       Impact factor: 7.403

5.  Complicated Infantile Hemangioma Successfully Treated with Topical Timolol 0.5% Solution: A Case Report.

Authors:  Nitin Borkar; Aarti Sharma; Dayanand Hota
Journal:  J Cutan Aesthet Surg       Date:  2021 Oct-Dec

6.  Evaluation of Transdermal Transport and Concurrent Cutaneous Hydrolysis of Timolol Prodrug for the Treatment of Infantile Hemangiomas.

Authors:  Shih-Jen Chang; Huiyuan Wang; Jialin Chen; Qianyi Chen; Lei Chang; Yongzhuo Huang; Yajing Qiu; Xiaoxi Lin
Journal:  Pharmaceutics       Date:  2022-08-01       Impact factor: 6.525

7.  Management of infantile hemangiomas during the COVID pandemic.

Authors:  Ilona J Frieden; Katherine B Püttgen; Beth A Drolet; Maria C Garzon; Sarah L Chamlin; Elena Pope; Anthony J Mancini; Christine T Lauren; Erin F Mathes; Dawn H Siegel; Deepti Gupta; Anita N Haggstrom; Megha M Tollefson; Eulalia Baselga; Kimberly D Morel; Sonal D Shah; Kristen E Holland; Denise M Adams; Kimberly A Horii; Brandon D Newell; Julie Powell; Catherine C McCuaig; Amy J Nopper; Denise W Metry; Sheilagh Maguiness
Journal:  Pediatr Dermatol       Date:  2020-05-16       Impact factor: 1.997

Review 8.  Topical beta-blockers in dermatologic therapy.

Authors:  Angela Filoni; Francesca Ambrogio; Aurora De Marco; Alessia Pacifico; Domenico Bonamonte
Journal:  Dermatol Ther       Date:  2021-06-21       Impact factor: 2.851
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.